Takeda Manufacturing Austria AG
PolandAll medications by this manufacturer
-
Antithrombin iii nf takeda
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Human antithrombin III 50 IU/ml; 500 IU ATC: B01AB02
-
Antithrombin iii nf takeda
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Human antithrombin III 1000 j.m. ATC: B01AB02
-
Artiss
Form: solution for preparation of tissue adhesive
Active substance Dosage Human fibrinogen 1 mg/ml Aprotinin 3000 KIU/ml Calcium chloride dihydrate 40 mcmol/ml Human thrombin 4 j.m./ml -
Feiba nf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Human plasma protein 20-60 mg/ml ATC: B02BD03
-
Feiba nf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Human plasma protein 20-60 mg/1 mL factor VIII inhibitor bypassing activity 50 units/1 mL ATC: B02BD03
-
Flexbumin 200 g/l
Form: solution for infusion
Active substance Dosage Human albumin 200 g/l ATC: B05AA01
-
Human albumin 200 g/l takeda
Form: solution for infusion
Active substance Dosage Human albumin 200 g/l ATC: B05AA01
-
Human albumin 50 g/l takeda
Form: solution for infusion
Active substance Dosage Human albumin 50 g/l ATC: B05AA01
-
Immunate 1000 iu fviii/750 iu vwf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor VIII 100 j.m./ml von Willebrand factor human 75 j.m./ml ATC: B02BD02
-
Immunate 250 iu fviii/190 iu vwf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor VIII 50 j.m./ml von Willebrand factor human 38 j.m./ml ATC: B02BD02
-
Immunate 500 iu fviii/375 iu vwf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor VIII 100 j.m./ml von Willebrand factor human 75 j.m./ml ATC: B02BD02
-
Immunine 1200 iu
Form: solution for injection or infusion, powder and solvent for preparation of
Active substance Dosage human coagulation factor IX 1200 j.m. ATC: B02BD04
-
Immunine 600 iu
Form: solution for injection or infusion, powder and solvent for preparation of
Active substance Dosage human coagulation factor IX 600 j.m. ATC: B02BD04
-
Prothromplex total nf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Human coagulation factor II 480 - 900 IU Human coagulation factor VII 500 j.m. Human coagulation factor IX 600 j.m. Human coagulation factor X 600 j.m. C protein 400 j.m. ATC: B02BD01
-
Prothromplex total nf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Human prothrombin complex 500 j.m. ATC: B02BD01
-
Rymphysia
Form: powder and solvent for preparation of concentrate for infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 500 mg ATC: B02AB02
-
Rymphysia
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human alpha1-proteinase inhibitor 1000 mg ATC: B02AB02
-
Tisseel
Form: solution for preparation of tissue adhesive
Active substance Dosage aprotinin 3000 KIU fibrinolysin humanum 91 mg thrombin 4 500 j.m. calcium chloride dihydrate 40 mcmol ATC: V03A
-
Tisseel lyo
Form: powder and solvent for preparation of tissue adhesive solution
Active substance Dosage Aprotinin 3000 KIU Calcium chloride dihydrate 40 mcmol Human fibrinogen 91 mg Human thrombin 500 j.m. ATC: V03A